Operating
Other Working Capital
Edwards Lifesciences Other Working Capital increased by 570.4% to $18.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 36.7%, from $28.60M to $18.10M. Over 3 years (FY 2021 to FY 2025), Other Working Capital shows an upward trend with a 22.9% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2015
Last reportedQ1 2026
How to read this metric
Positive changes suggest a source of cash from optimizing minor balance sheet items, while negative changes indicate cash is being tied up in these categories.
Detailed definition
The aggregate net change in miscellaneous operating assets and liabilities not specifically categorized in major line it...
Peer comparison
This is often used to reconcile net income to cash flow and varies based on a company's specific accounting classifications for 'other' items.
Metric ID:
change_in_other_working_capitalHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.50M | -$13.10M | $0.00 | $13.00M | $19.50M | $7.20M | $12.30M | -$6.20M | $1.50M | $19.50M | $4.20M | $5.10M | $1.00M | $11.10M | $28.60M | -$4.70M | $7.90M | $2.70M | $18.10M |
| QoQ Change | — | -254.1% | +100.0% | — | +50.0% | -63.1% | +70.8% | -150.4% | +124.2% | >999% | -78.5% | +21.4% | -80.4% | >999% | +157.7% | -116.4% | +268.1% | -65.8% | +570.4% |
| YoY Change | — | — | — | — | +129.4% | +155.0% | — | -147.7% | -92.3% | +170.8% | +167.7% | +240.0% | -94.9% | — | +581.0% | -192.2% | +690.0% | -75.7% | -36.7% |
Range-$13.10M – $28.60M
CAGR+18.3%
Avg YoY Growth+115.0%
Median YoY Growth+129.4%
Other Working Capital at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's other working capital?
- Edwards Lifesciences (EW) reported other working capital of $18.10M in Q1 2026.
- How has Edwards Lifesciences's other working capital changed year-over-year?
- Edwards Lifesciences's other working capital decreased by 36.7% year-over-year, from $28.60M to $18.10M.
- What is the long-term trend for Edwards Lifesciences's other working capital?
- Over 3 years (2021 to 2025), Edwards Lifesciences's other working capital has grown at a 22.9% compound annual growth rate (CAGR), from $18.60M to $34.50M.
- What does other working capital mean?
- The cash impact from changes in various smaller business assets and obligations used in daily operations.